nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—NISCH—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.196	0.196	CbGpPWpGaD
Naphazoline—ADRA1A—Endothelin Pathways—GNAS—adrenal gland cancer	0.02	0.02	CbGpPWpGaD
Naphazoline—ADRA1A—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0193	0.0193	CbGpPWpGaD
Naphazoline—ADRA2B—G alpha (z) signalling events—GNAS—adrenal gland cancer	0.0191	0.0191	CbGpPWpGaD
Naphazoline—ADRA2C—G alpha (z) signalling events—GNAS—adrenal gland cancer	0.0179	0.0179	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0161	0.0161	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (z) signalling events—GNAS—adrenal gland cancer	0.0145	0.0145	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0144	0.0144	CbGpPWpGaD
Naphazoline—ADRA2C—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.0144	0.0144	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0131	0.0131	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0122	0.0122	CbGpPWpGaD
Naphazoline—ADRA2A—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.0117	0.0117	CbGpPWpGaD
Naphazoline—ADRA2C—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.0116	0.0116	CbGpPWpGaD
Naphazoline—ADRA2C—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.0113	0.0113	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (12/13) signalling events—CDC42—adrenal gland cancer	0.0109	0.0109	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0107	0.0107	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00995	0.00995	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00991	0.00991	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00965	0.00965	CbGpPWpGaD
Naphazoline—ADRA2A—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.00945	0.00945	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00929	0.00929	CbGpPWpGaD
Naphazoline—ADRA2A—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00917	0.00917	CbGpPWpGaD
Naphazoline—ADRA2C—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00915	0.00915	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00863	0.00863	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00812	0.00812	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00783	0.00783	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00782	0.00782	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00755	0.00755	CbGpPWpGaD
Naphazoline—ADRA2A—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00743	0.00743	CbGpPWpGaD
Naphazoline—ADRA1A—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.0074	0.0074	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00732	0.00732	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00731	0.00731	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00697	0.00697	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00651	0.00651	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00639	0.00639	CbGpPWpGaD
Naphazoline—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.006	0.006	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00596	0.00596	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00594	0.00594	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00594	0.00594	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0057	0.0057	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00562	0.00562	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00561	0.00561	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00557	0.00557	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00541	0.00541	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—TSHR—adrenal gland cancer	0.00531	0.00531	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00529	0.00529	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00525	0.00525	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00524	0.00524	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0051	0.0051	CbGpPWpGaD
Naphazoline—ADRA2B—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0051	0.0051	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00505	0.00505	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—TSHR—adrenal gland cancer	0.00496	0.00496	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00487	0.00487	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00477	0.00477	CbGpPWpGaD
Naphazoline—ADRA2C—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00477	0.00477	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00459	0.00459	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00452	0.00452	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00434	0.00434	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00426	0.00426	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00426	0.00426	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00417	0.00417	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.0041	0.0041	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—SPARC—adrenal gland cancer	0.00404	0.00404	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00403	0.00403	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00387	0.00387	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00387	0.00387	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—SPARC—adrenal gland cancer	0.00377	0.00377	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—SDHB—adrenal gland cancer	0.00368	0.00368	CbGpPWpGaD
Naphazoline—ADRA1A—AMPK Signaling—TP53—adrenal gland cancer	0.00355	0.00355	CbGpPWpGaD
Naphazoline—ADRA2B—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00344	0.00344	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—PRKACA—adrenal gland cancer	0.00341	0.00341	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00337	0.00337	CbGpPWpGaD
Naphazoline—ADRA2C—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00321	0.00321	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—PRKACA—adrenal gland cancer	0.00318	0.00318	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00315	0.00315	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—GNAS—adrenal gland cancer	0.00309	0.00309	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—SPARC—adrenal gland cancer	0.00306	0.00306	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00306	0.00306	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GNRHR—adrenal gland cancer	0.00302	0.00302	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.003	0.003	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—SDHB—adrenal gland cancer	0.00299	0.00299	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—CDC42—adrenal gland cancer	0.00289	0.00289	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—GNAS—adrenal gland cancer	0.00289	0.00289	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00286	0.00286	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GNRHR—adrenal gland cancer	0.00282	0.00282	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0028	0.0028	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0028	0.0028	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—IGF2—adrenal gland cancer	0.00279	0.00279	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—GNAS—adrenal gland cancer	0.00276	0.00276	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00275	0.00275	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00273	0.00273	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00273	0.00273	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—CDC42—adrenal gland cancer	0.0027	0.0027	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00264	0.00264	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00262	0.00262	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00261	0.00261	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—IGF2—adrenal gland cancer	0.0026	0.0026	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—PRKACA—adrenal gland cancer	0.00259	0.00259	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—GNAS—adrenal gland cancer	0.00258	0.00258	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00255	0.00255	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00255	0.00255	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.00255	0.00255	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00252	0.00252	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0025	0.0025	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00246	0.00246	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00246	0.00246	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00245	0.00245	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—RRM1—adrenal gland cancer	0.00237	0.00237	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—SDHD—adrenal gland cancer	0.00237	0.00237	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00234	0.00234	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00232	0.00232	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00229	0.00229	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00229	0.00229	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00228	0.00228	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00223	0.00223	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00223	0.00223	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	0.00219	0.00219	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00215	0.00215	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00213	0.00213	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	0.0021	0.0021	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—POMC—adrenal gland cancer	0.00208	0.00208	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.002	0.002	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—POMC—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—SDHD—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—RRM1—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00183	0.00183	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00183	0.00183	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00181	0.00181	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—MED12—adrenal gland cancer	0.00177	0.00177	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00171	0.00171	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.00169	0.00169	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00166	0.00166	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TSHR—adrenal gland cancer	0.00161	0.00161	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.00159	0.00159	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.00158	0.00158	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.00155	0.00155	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MEN1—adrenal gland cancer	0.00151	0.00151	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TSHR—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00149	0.00149	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00148	0.00148	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.00148	0.00148	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00148	0.00148	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MED12—adrenal gland cancer	0.00144	0.00144	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00143	0.00143	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MEN1—adrenal gland cancer	0.00141	0.00141	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00139	0.00139	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00135	0.00135	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00135	0.00135	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00132	0.00132	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PRKACA—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.00124	0.00124	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GNAS—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000997	0.000997	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.00098	0.00098	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.00096	0.00096	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000945	0.000945	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000944	0.000944	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000937	0.000937	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000916	0.000916	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000913	0.000913	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000892	0.000892	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.000883	0.000883	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000882	0.000882	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000877	0.000877	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000875	0.000875	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000872	0.000872	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000853	0.000853	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.00085	0.00085	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000834	0.000834	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000825	0.000825	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.00081	0.00081	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.0008	0.0008	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000786	0.000786	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000771	0.000771	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000765	0.000765	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000746	0.000746	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000744	0.000744	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.000734	0.000734	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000717	0.000717	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000711	0.000711	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000704	0.000704	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000693	0.000693	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.000684	0.000684	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.00067	0.00067	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000642	0.000642	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.000639	0.000639	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000631	0.000631	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000623	0.000623	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000604	0.000604	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000597	0.000597	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.000589	0.000589	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000582	0.000582	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000572	0.000572	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000564	0.000564	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	0.000562	0.000562	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000559	0.000559	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000519	0.000519	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.000515	0.000515	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000508	0.000508	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000493	0.000493	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000478	0.000478	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000472	0.000472	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000458	0.000458	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	0.000456	0.000456	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00045	0.00045	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00042	0.00042	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000367	0.000367	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000357	0.000357	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000341	0.000341	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	0.000333	0.000333	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	0.000299	0.000299	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	0.000291	0.000291	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	0.00028	0.00028	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	0.000271	0.000271	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	0.000244	0.000244	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	0.000227	0.000227	CbGpPWpGaD
